Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Livanta is a U.S. healthcare technology and services company focused on government and regulated healthcare programs rather than therapeutics. Historically known as Livanta LLC, the business was acquired by Pleasant Land in 2024 and subsequently rebranded with affiliated businesses under the Commence name in 2025. Its services include Medicare quality improvement organization work, beneficiary advocacy, peer and independent medical review, federal independent dispute resolution under the No Surprises Act, fraud, waste and abuse support, and healthcare data transformation. The company serves federal health agencies, state and local government, and commercial healthcare organizations using a combination of clinical expertise, review operations, and data/AI-enabled workflow tools. It is healthcare-related, but it is not a drug-development biotech or pharma company and does not appear to operate a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Livanta.